Initial studies revealed that the expression of GLI1 and PTCH1 progressively increased in CML patient cells from the chronic phase (CP) through the accelerated phase (AP) and blast crisis phase (BC) of the disease [38,58,59]. The gene discussed is GLI1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.